S.A. Reva, A.K. Nosov, M.V. Berkut, S.B. Petrov
{"title":"375-miRNA在高危前列腺癌中的表达与新辅助治疗","authors":"S.A. Reva, A.K. Nosov, M.V. Berkut, S.B. Petrov","doi":"10.1016/S1569-9056(19)35011-0","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":12149,"journal":{"name":"European Urology Supplements","volume":"18 12","pages":"Pages e3625-e3626"},"PeriodicalIF":0.0000,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1569-9056(19)35011-0","citationCount":"0","resultStr":"{\"title\":\"375-miRNA expression and neoadjuvant therapy in high risk prostate cancer\",\"authors\":\"S.A. Reva, A.K. Nosov, M.V. Berkut, S.B. Petrov\",\"doi\":\"10.1016/S1569-9056(19)35011-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":12149,\"journal\":{\"name\":\"European Urology Supplements\",\"volume\":\"18 12\",\"pages\":\"Pages e3625-e3626\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/S1569-9056(19)35011-0\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Urology Supplements\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1569905619350110\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Urology Supplements","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1569905619350110","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0